Found 12 matching trials
the Efficacy and Safety of Ondansetron Oral Soluble Pellicles PHASE3 The name of this prospective study is a multicenter, open-label, randomized...
Show More Learn More & Join Trial
Antiemetic Fosaprepitant To Remedy Nausea and Vomiting PHASE2 The study team proposes a randomized, double-blind, RCT to address the foll...
Show More Location
Montefiore Medical Center (Montefiore and Weiler EDs)
Learn More & Join Trial
Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant As PONV Prevention NA As a preventive for postoperative nausea and vomiting in patients undergoin...
Show More Status
Enrolling By Invitation
Location
Samsung Medical Center
Learn More & Join Trial
An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) PHASE4 This protocol will study an investigational drug treatment plan against sta...
Show More Location
Multiple Locations
Learn More & Join Trial
Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting PHASE2 This study is aimed to evaluate the efficacy and safety of Fosrolapitant an...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation EARLY_PHASE1 The purpose of this study is to determine the efficacy of aprepitant in pre...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Efficacy of Aprepitant (Emend®) in Children PHASE3 The purpose of this study is to find out whether or not adding aprepitant(E...
Show More Location
Jimmy Everest Center for Cancer and Blood Disorders in Children
Learn More & Join Trial
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134) PHASE1 This study will determine the appropriate dosing regimen of aprepitant and ...
Show More Location
Multiple Locations
Learn More & Join Trial
HBPL Study of the Impact of the NK1 Antagonist Aprepitant PHASE2 The proposed research will focus on investigating the determinants and cons...
Show More Location
University of Pennsylvania, Treatment Research Center
Learn More & Join Trial
Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence PHASE2 The primary aim of the supplemental study is to provide POC testing of apre...
Show More Location
The Scripps Research Institute
Learn More & Join Trial